Valteau-Couanet D - Search Results

1

A dose-intensive approach (NB96) for induction therapy utilizing sequential high-dose chemotherapy and stem cell rescue in high-risk neuroblastoma in children over 1 year of age.

Monnereau-Laborde S, Munzer C, Valteau-Couanet D, Ansoborlo S, Coze C, Chastagner P, Rubie H, Demeocq F, Stephan JL, Hartmann O, Perel Y. Monnereau-Laborde S, et al. Pediatr Blood Cancer. 2011 Dec 1;57(6):965-71. doi: 10.1002/pbc.23232. Epub 2011 Jul 8. Pediatr Blood Cancer. 2011. PMID: 21744481 Clinical Trial.

2

Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.

Méresse V, Hartmann O, Vassal G, Benhamou E, Valteau-Couanet D, Brugieres L, Lemerle J. Méresse V, et al. Bone Marrow Transplant. 1992 Aug;10(2):135-41. Bone Marrow Transplant. 1992. PMID: 1525602

3

Is 600 mg/m2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation?

Vassal G, Deroussent A, Challine D, Hartmann O, Koscielny S, Valteau-Couanet D, Lemerle J, Gouyette A. Vassal G, et al. Blood. 1992 May 1;79(9):2475-9. Blood. 1992. PMID: 1571560 Free article.

4

Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma.

Patte C, Kalifa C, Flamant F, Hartmann O, Brugières L, Valteau-Couanet D, Bayle C, Caillaud JM, Lemerle J. Patte C, et al. Med Pediatr Oncol. 1992;20(2):105-13. doi: 10.1002/mpo.2950200204. Med Pediatr Oncol. 1992. PMID: 1734214

5

Nonmetastatic thoracic neuroblastomas: a review of 40 cases.

Rubie H, Hartmann O, Giron A, Lemoine G, Gruner M, Brugieres L, Valteau-Couanet D, Robert A, Lemerle J. Rubie H, et al. Med Pediatr Oncol. 1991;19(4):253-7. doi: 10.1002/mpo.2950190408. Med Pediatr Oncol. 1991. PMID: 2056969

6

Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological study.

Vassal G, Deroussent A, Hartmann O, Challine D, Benhamou E, Valteau-Couanet D, Brugières L, Kalifa C, Gouyette A, Lemerle J. Vassal G, et al. Cancer Res. 1990 Oct 1;50(19):6203-7. Cancer Res. 1990. PMID: 2400986

7

[Place of CSF in pediatric oncology].

Hartmann O, Valteau-Couanet D. Hartmann O, et al. Pathol Biol (Paris). 1993 Jan;41(1):52. Pathol Biol (Paris). 1993. PMID: 7686289 French. No abstract available.

8

[High dose chemotherapy followed by autologous bone marrow graft in solid tumors in children: arguments for].

Hartmann O, Valteau-Couanet D, Benhamou E. Hartmann O, et al. Bull Cancer. 1995 Jan;82(1):36-41. Bull Cancer. 1995. PMID: 7742613 Review. French.

9

[Humoral immunity and infections during bone marrow transplantation in children: study of 127 transplanted patients successively in a same center].

Grill J, Robert-Le Deley MC, Valteau-Couanet D, Brugières L, Kalifa C, Hartmann O. Grill J, et al. Arch Pediatr. 1994 May;1(5):463-9. Arch Pediatr. 1994. PMID: 7951830 French.

10

Antiinfective prophylaxis with ceftazidime and teicoplanin in children undergoing high-dose chemotherapy and bone marrow transplantation.

Avril M, Hartmann O, Valteau-Couanet D, Brugieres L, Kalifa C, Lemerle J. Avril M, et al. Pediatr Hematol Oncol. 1994 Jan-Feb;11(1):63-73. doi: 10.3109/08880019409141902. Pediatr Hematol Oncol. 1994. PMID: 8155502 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

218 results

Search Page